Home
Sanofi SNY paid Forbes-Tate $50K for lobbying in Q2 2026 · Taxation, Health Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2026
- Stock
- Sanofi SNY
- Client
- Sanofi U.S.
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in Sanofi around then
Filed or reported within 30 days of the trade day · 05/31~07/30Sanofi U.S.'s other lobbying reports
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 07/20
for Q2
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 04/20
for Q1
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 04/19
for Q1
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 01/20
for Q4 2025
- Sanofi U.S.
LobbyingSanofi
LobbyingSanofi
SNY
$50K
$50K
Reported 01/17
for Q4 2025